These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 38342723
21. Comparison of Microwave and Radiofrequency Ablation for the Treatment of Small- and Medium-Sized Hepatocellular Carcinomas in a Prospective Randomized Trial. Vogl TJ, Martin SS, Gruber-Rouh T, Booz C, Koch V, Nour-Eldin NA, Hussainy Said MN. Rofo; 2024 May; 196(5):482-490. PubMed ID: 38065541 [Abstract] [Full Text] [Related]
22. Microwave ablation after downstaging of hepatocellular carcinoma: outcome was similar to tumor within Milan criteria. Shi F, Lian S, Mai Q, Mo Z, Zhuang W, Cui W, Shen L, Chen M, Wu P, Chen X. Eur Radiol; 2020 May; 30(5):2454-2462. PubMed ID: 32002636 [Abstract] [Full Text] [Related]
23. Radiofrequency ablation versus microwave ablation for hepatocellular carcinoma with cirrhosis: a propensity score analysis. Xiong Y, Zhang Y, Hu C. Transl Cancer Res; 2024 Apr 30; 13(4):1807-1820. PubMed ID: 38737685 [Abstract] [Full Text] [Related]
24. Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis. Suwa K, Seki T, Aoi K, Yamashina M, Murata M, Yamashiki N, Nishio A, Shimatani M, Naganuma M. Abdom Radiol (NY); 2021 Aug 30; 46(8):3790-3797. PubMed ID: 33675382 [Abstract] [Full Text] [Related]
25. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma. Xu Y, Shen Q, Wang N, Wu PP, Huang B, Kuang M, Qian GJ. Chin J Cancer; 2017 Jan 19; 36(1):14. PubMed ID: 28103953 [Abstract] [Full Text] [Related]
26. Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching. Wu Z, Tang H, Wang L, Jin X, Lei Z, Yang P, Zhou J. BMC Surg; 2022 Mar 21; 22(1):103. PubMed ID: 35313836 [Abstract] [Full Text] [Related]
27. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes. Lee S, Kang TW, Cha DI, Song KD, Lee MW, Rhim H, Lim HK, Sinn DH, Kim JM, Kim K. J Hepatol; 2018 Jul 21; 69(1):70-78. PubMed ID: 29524532 [Abstract] [Full Text] [Related]
28. Microwave ablation versus surgical resection for subcapsular hepatocellular carcinoma: a propensity score-matched study of long-term therapeutic outcomes. Liu K, Zheng H, Sui X, Liu B, Meng M, Feng Y, Zhu Q, Zhao X. Eur Radiol; 2023 Mar 21; 33(3):1938-1948. PubMed ID: 36114849 [Abstract] [Full Text] [Related]
29. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis. An C, Li WZ, Huang ZM, Yu XL, Han YZ, Liu FY, Wu SS, Yu J, Liang P, Huang J. Eur Radiol; 2021 Jul 21; 31(7):4764-4773. PubMed ID: 33399908 [Abstract] [Full Text] [Related]
30. Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma. Lee J, Jin YJ, Shin SK, Kwon JH, Kim SG, Suh YJ, Jeong Y, Yu JH, Lee JW, Kwon OS, Nahm SW, Kim YS. Clin Mol Hepatol; 2022 Apr 21; 28(2):207-218. PubMed ID: 34814239 [Abstract] [Full Text] [Related]
31. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection. Feng Y, Wu H, Huang DQ, Xu C, Zheng H, Maeda M, Zhao X, Wang L, Xiao F, Lv H, Liu T, Qi J, Li J, Zhong N, Wang C, Feng H, Liang B, Ren W, Qin C, Nguyen MH, Zhu Q. Eur Radiol; 2020 Nov 21; 30(11):6357-6368. PubMed ID: 32529568 [Abstract] [Full Text] [Related]
32. Single Hepatocellular Carcinoma approached by curative-intent treatment: A propensity score analysis comparing radiofrequency ablation and liver resection. Di Sandro S, Benuzzi L, Lauterio A, Botta F, De Carlis R, Najjar M, Centonze L, Danieli M, Pezzoli I, Rampoldi A, Bagnardi V, De Carlis L. Eur J Surg Oncol; 2019 Sep 21; 45(9):1691-1699. PubMed ID: 31072620 [Abstract] [Full Text] [Related]
33. Anatomic resection versus radiofrequency ablation with an ablative margin ≥ 1.0 cm for solitary small hepatocellular carcinoma measuring ≤ 3 cm: Comparison of long-term outcomes using propensity score matching analysis. Zhang C, Gao R, Guo S, Ning C, Li A, Wang X, Li S, Ding J, Kong X, Wang Q, Xu Y, Li J, Gao J, Wang S, Kong J, Ke S, Sun W. Eur J Radiol; 2022 Oct 21; 155():110498. PubMed ID: 36049409 [Abstract] [Full Text] [Related]
34. Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching. Du S, Yang JZ, Chen J, Zhou WG, Sun YY. PLoS One; 2020 Oct 21; 15(1):e0227242. PubMed ID: 31918433 [Abstract] [Full Text] [Related]
35. Tumor size may influence the prognosis of solitary hepatocellular carcinoma patients with cirrhosis and without macrovascular invasion after hepatectomy. Liang BY, Gu J, Xiong M, Zhang EL, Zhang ZY, Chen XP, Huang ZY. Sci Rep; 2021 Aug 11; 11(1):16343. PubMed ID: 34381132 [Abstract] [Full Text] [Related]
36. Therapeutic efficacy of percutaneous microwave coagulation versus liver resection for single hepatocellular carcinoma ≤3 cm with Child-Pugh A cirrhosis. Zhang EL, Yang F, Wu ZB, Yue CS, He TY, Li KY, Xiao ZY, Xiong M, Chen XP, Huang ZY. Eur J Surg Oncol; 2016 May 11; 42(5):690-7. PubMed ID: 26995115 [Abstract] [Full Text] [Related]
38. LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation. Min JH, Lee MW, Rhim H, Han S, Song KD, Kang TW, Jeong WK, Cha DI, Kim JM, Choi GS, Kim K. Eur Radiol; 2024 Jan 11; 34(1):525-537. PubMed ID: 37526668 [Abstract] [Full Text] [Related]